FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ultrasonic diagnostics, cardiology and cardiosurgery, and can be used for diagnosing left ventricular (LV) remodelling with its intact ejection fraction and predicting the development of heart failure in patients with ischemic heart disease. Three-dimensional stress echocardiography with sodium adenosine triphosphate is performed. At the peak of the stress test, myocardial deformation values are recorded by speckle-tracking. Echocardiographic prognostic criterion of remodelling development (Y) is calculated. If the value Y is more than or equal to 2.1, the development of unfavourable remodelling with the development of heart failure is predicted. If Y is less than 2.1, favourable remodelling without developing heart failure is predicted.
EFFECT: method provides detecting patients with a high risk of unfavourable remodelling and enables timely correction of the therapeutic action plan in order to prevent the development of heart failure; in the presence of signs of unfavourable remodelling and significant coronary artery disease detected by coronary angiography, surgical revascularization of LV myocardium can be recommended.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR ACHIEVING THE STAGE OF STABLE SUBMAXIMAL HYPEREMIA OF THE MYOCARDIUM WHEN CARRYING OUT A LOADING TEST WITH INTRAVENOUS INFUSION ADENOSINE TRIPHOSPHATE | 2018 |
|
RU2688441C1 |
| METHOD FOR DIAGNOSING THE CASES OF CARDIAC ISCHEMIA DISEASE | 2004 |
|
RU2245680C1 |
| METHOD FOR ASSESSING LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN SMOKERS WITH EARLY STAGES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE OF LIGHT DEGREE AND ARTERIAL HYPERTENSION OF I STAGE | 2020 |
|
RU2743245C1 |
| METHOD FOR PREDICTING CARDIAC INSUFFICIENCY IN CARDIAC ISCHEMIA PATIENTS IN POSTINFARCTION PERIOD | 2004 |
|
RU2269922C1 |
| METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION AND ATRIAL FIBRILLATION ON THE BACKGROUND OF CARDIAC CONTRACTILITY MODULATION THERAPY | 2023 |
|
RU2804590C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING REPEATED REMODELING OF THE LEFT VENTRICULAR MYOCARDIUM WITHIN 12 MONTHS AFTER SURGICAL TREATMENT OF ISCHEMIC CARDIOMYOPATHY | 2020 |
|
RU2745473C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC CARDIAC FAILURE OF ISCHEMIC GENESIS | 2010 |
|
RU2424015C2 |
| METHOD FOR DETERMINING INDICATIONS TO SURGICAL TREATMENT OF CARDIAC ISCHEMIA PATIENTS SURVIVED AFTER MYOCARDIAL INFARCTION | 2004 |
|
RU2269934C1 |
| METHOD OF SELECTING PATIENTS WITH DECOMPENSATED ISCHEMIC CHRONIC CARDIAC FAILURE TO PERFORM ENDOMYOCARDIAL BIOPSY | 2019 |
|
RU2728095C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVORABLE REMODELING OF THE LEFT VENTRICLE OF THE HEART IN PATIENTS WITH ACUTE ANTERIOR MYOCARDIAL INFARCTION WITH ST STENT ELEVATION WITHIN 6 MONTHS OF THE ONSET OF THE DISEASE | 2017 |
|
RU2662093C1 |
